Background & Aims
The impact of hepatitis B virus (HBV) or hepatitis C virus (HCV) infection upon B vitamins status and antioxidative defense in infected patients was examined.
Dietary record and blood levels of B vitamins and oxidative stress–associated biomarkers were determined for 195 healthy controls, 132 HBV, and 114 HCV patients.
HBV-infected patients had significantly higher levels of total cholesterol, free fatty acids (FFA), and lower ghrelin level (p < 0.05); and HCV-infected patients had significantly higher Ishak inflammation score and lactate dehydrogenase activity (p < 0.05). HBV patients had significantly lower red blood cell (RBC) vitamins B2 and B6 levels, and HCV infection significantly decreased vitamins B2, B6 and folate levels in RBC and/or plasma (p < 0.05). Correlation coefficients of RBC vitamin B2 versus serum FFA in HBV patients, RBC vitamins B2 and B6 versus HCV RNA and Ishak inflammation score, and plasma vitamin B6 vs Ishak inflammation score in HCV patients were <−0.5. HBV-infected patients had significantly higher oxidized glutathione level and lower glutathione peroxidase activity (p < 0.05), but HCV patients had significantly lower superoxide dismutase and catalase activities (p < 0.05).
HBV or HCV infection enhanced oxidative stress and lowered B vitamins in circulation. In order to avoid other healthy risk, nutrition status should be monitored and limitation or supplementation of certain nutrients might be helpful for HBV- or HCV-infected patients.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Hepatitis B virus
Hepatitis C virus
High density lipoprotein
Low density lipoprotein
Tan A, Yeh SH, Liu CJ, Cheung C, Chen PJ (2008) Viral hepatocarcinogenesis: from infection to cancer. Liver Int 28:175–188
Fung J, Lai CL, Yuen MF (2009) Hepatitis B and C virus-related carcinogenesis. Clin Microbiol Infect 15:964–970
Lim YS, Kim WR (2008) The global impact of hepatic fibrosis and end-stage liver disease. Clin Liver Dis 12:733–746
Wu JT, Kral JG (2004) Ghrelin: integrative neuroendocrine peptide in health and disease. Ann Surg 239:464–474
Lin CC, Yin MC (2007) B vitamins deficiency and decreased anti-oxidant state in patients with liver cancer. Eur J Nutr 46:293–299
Nair J, Srivatanakul P, Haas C, Jedpiyawongse A, Khuhaprema T, Seitz HK, Bartsch H (2010) High urinary excretion of lipid peroxidation-derived DNA damage in patients with cancer-prone liver diseases. Mutat Res 683:23–28
Swietek K, Juszczyk J (1997) Reduced glutathione concentration in erythrocytes of patients with acute and chronic viral hepatitis. J Viral Hepat 4:139–141
Chrobot AM, Szaflarska-Szczepanik A, Drewa G (2000) Antioxidant defense in children with chronic viral hepatitis B and C. Med Sci Monit 6:713–718
Fujita N, Sugimoto R, Ma N, Tanaka H, Iwasa M, Kobayashi Y, Kawanishi S, Watanabe S, Kaito M, Takei Y (2008) Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C. J Viral Hepat 15:498–507
Di Bisceglie AM, Shiffman ML, Everson GT, Lindsay KL, Everhart JE, Wright EC, Lee WM, Lok AS, Bonkovsky HL, Morgan TR, Ghany MG, Morishima C, Snow KK, Dienstag JL, HALT-C Trial Investigators (2008) Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. N Engl J Med 359:2429–2441
Department of Health (1998) Taiwan nutrient databases 1998. Department of Health, Executive Yuan, Taipei
Talwar D, Ha T, Cooney J, Cooney J, Brownlee C, O’Reilly DS (1998) A routine method for the simultaneous measurement of retinol, α-tocopherol and five carotenoids in human plasma by reverse phase HPLC. Clin Chim Acta 270:85–100
Karlsen A, Blomhoff R, Gundersen TE (2005) High-throughput analysis of vitamin C in human plasma with the use of HPLC with monolithic column and UV-detection. J Chromatogr B Analyt Technol Biomed Life Sci 824:132–138
Prajda N, Weber G (1975) Malignant transformation-linked imbalance: decreased XO activity in hepatomas. FEBS Lett 59:245–249
Talwar D, Davidson H, Cooney J, St JO’Reilly D (2000) Vitamin B (1) status assessed by direct measurement of thiamin pyrophosphate in erythrocytes or whole blood by HPLC: comparison with erythrocyte transketolase activation assay. Clin Chem 46:704–710
Speek AJ, van Schaik F, Schrijver J, Schreurs WH (1982) Determination of the B2 vitamer flavin—adenine dinucleotide in whole blood by high-performance liquid chromatography with fluorometric detection. J Chromatogr 228:311–316
Talwar D, Quasim T, McMillan DC, Kinsella J, Williamson C, O’Reilly DS (2003) Optimisation and validation of a sensitive high-performance liquid chromatography assay for routine measurement of pyridoxal 5-phosphate in human plasma and red cells using pre-column semicarbazide derivatisation. J Chromatogr B Analyt Technol Biomed 792:333–343
Hong YC, Lee KH, Yi CH, Ha EH, Christiani DC (2002) Genetic susceptibility of term pregnant women to oxidative damage. Toxicol Lett 129:255–262
Konishi M, Iwasa M, Araki J, Kobayashi Y, Katsuki A, Sumida Y, Nakagawa N, Kojima Y, Watanabe S, Adachi Y, Kaito M (2006) Increased lipid peroxidation in patients with non-alcoholic fatty liver disease and chronic hepatitis C as measured by the plasma level of 8-isoprostane. J Gastroenterol Hepatol 21:1821–1825
Pellicano R, Puglisi G, Ciancio A, Balzola F, Saracco G, Ciccone G, Baldi I, Abate ML, Smedile A, Rizzetto M (2008) Is serum uric acid a predictive factor of response to IFN-treatment in patients with chronic hepatitis C infection? J Med Virol 80:628–631
Moriya K, Shintani Y, Fujie H, Miyoshi H, Tsutsumi T, Yotsuyanagi H, Iino S, Kimura S, Koike K (2003) Serum lipid profile of patients with genotype 1b hepatitis C viral infection in Japan. Hepatol Res 25:371–376
Kim KH, Shin HJ, Kim K, Choi HM, Rhee SH, Moon HB, Kim HH, Yang US, Yu DY, Cheong J (2007) Hepatitis B virus X protein induces hepatic steatosis via transcriptional activation of SREBP1 and PPARgamma. Gastroenterology 132:1955–1967
Russell AP, Schrauwen P, Somm E, Gastaldi G, Hesselink MK, Schaart G, Kornips E, Lo SK, Bufano D, Giacobino JP, Muzzin P, Ceccon M, Angelini C, Vergani L (2003) Decreased fatty acid beta-oxidation in riboflavin-responsive, multiple acylcoenzyme A dehydrogenase-deficient patients is associated with an increase in uncoupling protein-3. J Clin Endocrinol Metab 88:5921–5926
Morris AA, Turnbull DM (1998) Fatty acid oxidation defects in muscle. Curr Opin Neurol 11:485–490
Hosoda H, Kojima M, Kangawa K (2006) Biological, physiological, and pharmacological aspects of ghrelin. J Pharmacol Sci 100:398–410
Legakis I, Stathopoulos J, Matzouridis T, Stathopoulos GP (2009) Decreased plasma ghrelin levels in patients with advanced cancer and weight loss in comparison to healthy individuals. Anticancer Res 29:3949–3952
Gori AM, Sofi F, Marcucci R, Giusti B, Franco Gensini G, Abbate R (2007) Association between homocysteine, vitamin B(6) concentrations and inflammation. Clin Chem Lab Med 45:1728–1736
Ullegaddi R, Powers HJ, Gariballa SE (2004) B-group vitamin supplementation mitigates oxidative damage after acute ischaemic stroke. Clin Sci (Lond) 107:477–484
Rivlin RS (1986) Riboflavin. Adv Exp Med Biol 206:349–355
McGowan C (1989) Influence of vitamin B6 status on aspects of lead poisoning in rats. Toxicol Lett 47:87–93
Bolukbas C, Bolukbas FF, Horoz M, Aslan M, Celik H, Erel O (2005) Increased oxidative stress associated with the severity of the liver disease in various forms of hepatitis B virus infection. BMC Infect Dis 5:95–102
Choi J, Ou JH (2006) Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. Am J Physiol Gastrointest Liver Physiol 290:847–851
Authors, Lin CC, Liu WH, Wang ZH and Yin MC, would like to thank all subjects participated in this study.
Conflict of interest
None of the authors reports a conflict of interest.
About this article
Cite this article
Lin, Cc., Liu, Wh., Wang, Zh. et al. Vitamins B status and antioxidative defense in patients with chronic hepatitis B or hepatitis C virus infection. Eur J Nutr 50, 499–506 (2011). https://doi.org/10.1007/s00394-010-0156-1